Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.

Zimmerman M, Lestner J, Prideaux B, O'Brien P, Dias-Freedman I, Chen C, Dietzold J, Daudelin I, Kaya F, Blanc L, Chen PY, Park S, Salgame P, Sarathy J, Dartois V

Open source

DOI
10.1128/aac.00924-17
Published
2017 Sep
Container
Antimicrobial agents and chemotherapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/aac.00924-17,
  title = {Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.},
  author = {Zimmerman M and Lestner J and Prideaux B and O'Brien P and Dias-Freedman I and Chen C and Dietzold J and Daudelin I and Kaya F and Blanc L and Chen PY and Park S and Salgame P and Sarathy J and Dartois V},
  year = {2017},
  journal = {Antimicrobial agents and chemotherapy},
  doi = {10.1128/aac.00924-17},
  url = {https://doi.org/10.1128/aac.00924-17}
}

RIS

TY  - JOUR
TI  - Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.
AU  - Zimmerman M
AU  - Lestner J
AU  - Prideaux B
AU  - O'Brien P
AU  - Dias-Freedman I
AU  - Chen C
AU  - Dietzold J
AU  - Daudelin I
AU  - Kaya F
AU  - Blanc L
AU  - Chen PY
AU  - Park S
AU  - Salgame P
AU  - Sarathy J
AU  - Dartois V
PY  - 2017
JO  - Antimicrobial agents and chemotherapy
DO  - 10.1128/aac.00924-17
UR  - https://doi.org/10.1128/aac.00924-17
ER  - 

APA

M, Z., J, L., B, P., P, O., I, D., C, C., J, D., I, D., F, K., L, B., PY, C., S, P., P, S., J, S., & V, D. (2017). Ethambutol Partitioning in Tuberculous Pulmonary Lesions Explains Its Clinical Efficacy.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.00924-17

Source records